Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease
The inspection, conducted from June 23 to June 25, 2025, concluded with zero Form 483 observations
Guidelines aim to establish state-regulated veterinary blood banks
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
Sarepta has also entered into an agreement with Arrowhead to transfer 2,660,989 shares of Arrowhead common stock in satisfaction of $50 million of the company’s previously announced $100 million milestone payment obligation
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Subscribe To Our Newsletter & Stay Updated
